Skip to main content
ConductScienceScienceDex

Lishomwa C Ndhlovu

NIH Rank #240
Unclaimed recordClaim profile
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Translational
  • Multi-Institutional
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9476960Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine
  • Pathology
  • VETERINARY SCIENCES
  • Microbiology & Immunology
  • Neurosciences

NIH Funding · FY2025

Linked Award Amount
$13.8M
Full award amounts, FY2025
Award Records
9
Records listing this PI
Award-Linked Rank
#240
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Lishomwa C Ndhlovu. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Lishomwa C Ndhlovu as a PI. Multi-PI records show the full award amount for context.

  • 5UM1AI164559-05UM1
    HOPE - HIV Obstruction by Programmed Epigenetics
    J. David Gladstone Institutes
    $5M
    award amount
  • 5U01DA058527-03U01
    Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure
    Weill Cornell Medicine
    $2.3M
    award amount
  • 1R37AI189285-01A1R37
    Characterization of Allogeneic T Cells Mediating HIV Cure
    Oregon Health & Science University
    $1.7M
    award amount
  • 5R01MH130197-04R01
    Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence
    Henry M. Jackson Fdn for the Adv Mil/Med
    $974.1K
    award amount
  • 5R01MH130177-04R01
    Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV
    University of Minnesota
    $893.5K
    award amount
  • 5R01AI184421-02R01
    Modulation of Galectin-9 to Target HIV Persistence
    Vitalant
    $827.5K
    award amount
  • 5R01AI179324-03R01
    Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection
    University of Pittsburgh
    $784.9K
    award amount
  • 5U01DA053625-05U01
    Integrative Single Cell isoform and chromatin accessibility Mapping of Chronic Opioid Exposure in Cognitive Brain Areas in HIV
    Weill Cornell Medicine
    $768.2K
    award amount
  • 1R01DA063076-01R01
    Single cell dark matter in the context of HIV and substance use
    Feinstein Institute for Medical Research
    $616.4K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Lishomwa C Ndhlovu as a PI.

J. David Gladstone Institutes
CA
$5M
1 grant
Weill Cornell Medicine
NY
$3M
2 grants
Oregon Health & Science University
OR
$1.7M
1 grant
Henry M. Jackson Fdn for the Adv Mil/Med
MD
$974.1K
1 grant
University of Minnesota
MN
$893.5K
1 grant
Vitalant
AZ
$827.5K
1 grant
University of Pittsburgh
PA
$784.9K
1 grant
Feinstein Institute for Medical Research
NY
$616.4K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    J. David Gladstone Institutes
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #231
  8. 2024
    Entered Top 25% Nationally
    Ranked #231
  9. 2024
    Entered Top 10% Nationally
    Ranked #231
  10. 2024
    Entered Top 5% Nationally
    Ranked #231
  11. 2025
    $25M Cumulative Funding
  12. 2025
    Multi-Institutional Research
    Awards at 8 institutions
  13. 2025
    R01 Grant Holder
  14. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Lishomwa C Ndhlovu.

Charles A. Scanga
University of Pittsburgh
3
shared awards
Dionna Whitney Williams
Weill Cornell Medicine
3
shared awards
Michael Jay Corley
Weill Cornell Medicine
3
shared awards
Pamela J Skinner
University of Minnesota
3
shared awards
Satish Kumar Pillai
Vitalant
3
shared awards
Shelby L Oconnor
University of Pittsburgh
3
shared awards
Siddappa N Byrareddy
University of Minnesota
3
shared awards
Victor Valcour
Weill Cornell Medicine
3
shared awards
Afamefuna Okoye
Henry M. Jackson Fdn for the Adv Mil/Med
2
shared awards
Douglas F Nixon
Feinstein Institute for Medical Research
2
shared awards

Explore further

Find collaborators for Lishomwa C Ndhlovu

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →
Lishomwa C Ndhlovu | NIH Award Records | ConductScience